SE9901573D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9901573D0 SE9901573D0 SE9901573A SE9901573A SE9901573D0 SE 9901573 D0 SE9901573 D0 SE 9901573D0 SE 9901573 A SE9901573 A SE 9901573A SE 9901573 A SE9901573 A SE 9901573A SE 9901573 D0 SE9901573 D0 SE 9901573D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- solvates
- pharmaceutically acceptable
- new compounds
- carboxypeptidase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (55)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901573A SE9901573D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
ARP000102084A AR023819A1 (es) | 1999-05-03 | 2000-04-28 | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
ARP000102083A AR034241A1 (es) | 1999-05-03 | 2000-04-28 | Compuestos que inhiben carboxipeptidasas, un proceso para su preparacion, una formulacion farmaceutica que los contiene y uso de los mismos para la fabricacion de un medicamento |
MYPI20001883A MY128014A (en) | 1999-05-03 | 2000-05-02 | Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors |
MYPI20001884A MY126962A (en) | 1999-05-03 | 2000-05-02 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
TR2001/03151T TR200103151T2 (tr) | 1999-05-03 | 2000-05-03 | Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon. |
CA002371213A CA2371213C (en) | 1999-05-03 | 2000-05-03 | Inhibitors of carboxypeptidase u |
TR2001/03153T TR200103153T2 (tr) | 1999-05-03 | 2000-05-03 | Yeni bileşimler |
KR1020017014011A KR100755152B1 (ko) | 1999-05-03 | 2000-05-03 | 신규 화합물 |
US09/600,659 US6974800B1 (en) | 1999-05-03 | 2000-05-03 | Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor |
CA002371217A CA2371217A1 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
CNB008094829A CN1263739C (zh) | 1999-05-03 | 2000-05-03 | 羧肽酶u抑制化合物、其制备方法、含有该化合物的药物组合物及其用途 |
US09/600,661 US7071175B1 (en) | 1999-05-03 | 2000-05-03 | Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
CNB008071284A CN100518820C (zh) | 1999-05-03 | 2000-05-03 | 含有羧肽酶u抑制剂和凝血酶抑制剂的药物制剂 |
AU47902/00A AU771760B2 (en) | 1999-05-03 | 2000-05-03 | New compounds |
TW089108401A TWI232106B (en) | 1999-05-03 | 2000-05-03 | Pharmaceutical compositions and kits of parts for the treatment of a patient suffering from or susceptible to a condition in which inhibition of thrombin and/or inhibition of carboxypeptidase U are required or desired |
MXPA01011055A MXPA01011055A (es) | 1999-05-03 | 2000-05-03 | Nuevos compuestos que inhiben las carboxipeptidasas basicas.. |
BR0010257-1A BR0010257A (pt) | 1999-05-03 | 2000-05-03 | Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, método para tratamento ou profilaxia de condições associadas com a inibição da carboxipeptidase u, kits de partes, e, método de tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da carboxipeptidase u e um mecanismo antitrombótico diferente são necessários ou desejados |
NZ515063A NZ515063A (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
DE60043297T DE60043297D1 (de) | 1999-05-03 | 2000-05-03 | Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor |
JP2000615388A JP2002543184A (ja) | 1999-05-03 | 2000-05-03 | 新規化合物 |
ES00925845T ES2335383T3 (es) | 1999-05-03 | 2000-05-03 | Una formulacion farmaceutica que contiene un inhibidor de carboxipeptidasa y un inhibidor de trombina. |
EP00930001A EP1180098A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
IL14595400A IL145954A0 (en) | 1999-05-03 | 2000-05-03 | A new inhibitor of carboxypeptidase u |
NZ515062A NZ515062A (en) | 1999-05-03 | 2000-05-03 | New compounds, and pharmaceutically acceptable salts thereof, which inhibit basic carboxypeptidases |
MXPA01011044A MXPA01011044A (es) | 1999-05-03 | 2000-05-03 | Formulacion farmaceutica que contiene un inhibidor de carboxipeptidasa u y un inhibidor de trombina.. |
EEP200100574A EE04490B1 (et) | 1999-05-03 | 2000-05-03 | Ühend, selle valmistamise meetod ning kasutamine meditsiinis |
KR1020017014009A KR100725206B1 (ko) | 1999-05-03 | 2000-05-03 | 카르복시펩티다제 u 억제제 및 트롬빈 억제제를 함유하는제약 제제 |
PCT/SE2000/000834 WO2000066557A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
SK1546-2001A SK15462001A3 (sk) | 1999-05-03 | 2000-05-03 | Deriváty etántiolu, spôsoby ich prípravy, farmaceutické prípravky s ich obsahom a ich použitie na liečenie |
CZ20013932A CZ20013932A3 (cs) | 1999-05-03 | 2000-05-03 | Farmaceutický prostředek obsahující inhibitor karboxyperoxidasy U a inhibitor thrombinu |
BR0010255-5A BR0010255A (pt) | 1999-05-03 | 2000-05-03 | Formulação farmacêutica, kit de partes, método para tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da trombina e/ou inibição da carboxipeptidase u são requeridas ou desejadas, e, uso de uma formulação |
PL354360A PL200932B1 (pl) | 1999-05-03 | 2000-05-03 | Nowe związki, środek farmaceutyczny i zastosowanie nowych związków |
PCT/SE2000/000847 WO2000066152A1 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
SK1565-2001A SK15652001A3 (sk) | 1999-05-03 | 2000-05-03 | Farmaceutický prípravok obsahujúci inhibítor karboxypeptidázy U a inhibítor trombínu |
IL14595100A IL145951A0 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
AU44472/00A AU763772B2 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
TW089108400A TWI232105B (en) | 1999-05-03 | 2000-05-03 | Novel compounds and their preparation process and pharmaceutical formulation containing the same |
CZ20013930A CZ20013930A3 (cs) | 1999-05-03 | 2000-05-03 | Nové sloučeniny |
RU2001128158/15A RU2242992C2 (ru) | 1999-05-03 | 2000-05-03 | Фармацевтический препарат, содержащий ингибитор карбоксипептидазы u и ингибитор тромбина |
AT00925845T ATE447964T1 (de) | 1999-05-03 | 2000-05-03 | Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor |
JP2000615036A JP2002543148A (ja) | 1999-05-03 | 2000-05-03 | カルボキシペプチダーゼu阻害剤とトロンビン阻害剤とを含有する医薬製剤 |
EEP200100578A EE200100578A (et) | 1999-05-03 | 2000-05-03 | Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat |
EP00925845A EP1181048B1 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
RU2001128159/04A RU2244708C2 (ru) | 1999-05-03 | 2000-05-03 | Серусодержащие соединения, способы их получения и фармацевтические препараты на их основе |
HU0202876A HUP0202876A3 (en) | 1999-05-03 | 2000-05-03 | Carboxypeptidase u inhibiting new compounds, process for their preparation and pharmaceutical compositions containing them and their use |
PL356119A PL203505B1 (pl) | 1999-05-03 | 2000-05-03 | Preparat farmaceutyczny zawieraj acy inhibitor karboksypeptydazy U i inhibitor trombiny, zestaw sk ladników i zastosowanie preparatu farmaceutycznego |
HU0201615A HUP0201615A3 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
NO20015308A NO20015308L (no) | 1999-05-03 | 2001-10-30 | En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor |
ZA200108968A ZA200108968B (en) | 1999-05-03 | 2001-10-30 | New compounds. |
IS6139A IS6139A (is) | 1999-05-03 | 2001-11-01 | Ný efnasambönd |
IS6140A IS6140A (is) | 1999-05-03 | 2001-11-01 | Lyfjablanda sem inniheldur hemil karboxýpeptíðasaU og þrombínhemil |
NO20015383A NO321377B1 (no) | 1999-05-03 | 2001-11-02 | Nye forbindelser |
HK02104300.5A HK1042303A1 (zh) | 1999-05-03 | 2002-06-06 | 新的化合物 |
HK02104301.4A HK1042442B (zh) | 1999-05-03 | 2002-06-06 | 含有羧肽酶u抑制劑和凝血酶抑制劑的藥物製劑 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9901573A SE9901573D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9901573D0 true SE9901573D0 (sv) | 1999-05-03 |
Family
ID=20415426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9901573A SE9901573D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
Country Status (27)
Country | Link |
---|---|
US (1) | US7071175B1 (xx) |
EP (1) | EP1180098A1 (xx) |
JP (1) | JP2002543184A (xx) |
KR (1) | KR100755152B1 (xx) |
CN (1) | CN1263739C (xx) |
AR (1) | AR034241A1 (xx) |
AU (1) | AU771760B2 (xx) |
BR (1) | BR0010257A (xx) |
CA (1) | CA2371213C (xx) |
CZ (1) | CZ20013930A3 (xx) |
EE (1) | EE04490B1 (xx) |
HK (1) | HK1042303A1 (xx) |
HU (1) | HUP0202876A3 (xx) |
IL (1) | IL145954A0 (xx) |
IS (1) | IS6139A (xx) |
MX (1) | MXPA01011055A (xx) |
MY (1) | MY128014A (xx) |
NO (1) | NO321377B1 (xx) |
NZ (1) | NZ515062A (xx) |
PL (1) | PL200932B1 (xx) |
RU (1) | RU2244708C2 (xx) |
SE (1) | SE9901573D0 (xx) |
SK (1) | SK15462001A3 (xx) |
TR (1) | TR200103153T2 (xx) |
TW (1) | TWI232105B (xx) |
WO (1) | WO2000066557A1 (xx) |
ZA (1) | ZA200108968B (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828566B2 (en) * | 1997-07-22 | 2004-12-07 | Hitachi Ltd | Method and apparatus for specimen fabrication |
SE9901572D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
MXPA02002671A (es) | 1999-09-14 | 2002-07-30 | Meiji Seika Kaisha | Derivado de acido fosfonico que tiene actividad inhibidora contra la carboxipeptidasa b. |
SE0103272D0 (sv) | 2001-09-28 | 2001-09-28 | Astrazeneca Ab | Chemical compounds |
US6713496B2 (en) | 2002-01-22 | 2004-03-30 | Pfizer Inc | 3-(imidazolyl)-2-alkoxypropanoic acids |
BR0307033A (pt) | 2002-01-22 | 2004-12-07 | Pfizer | ácidos 3-(imidazolil)-2-aminopropanóicos para o uso como inibidores tafi-a para o tratamento de doenças trombóticas |
EP1497300A2 (en) * | 2002-03-21 | 2005-01-19 | Schering Aktiengesellschaft | Plasma carboxypeptidase b inhibitors |
CA2486402C (en) | 2002-05-22 | 2013-04-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors based on alpha-chalcogenmethylcarbonyl compounds |
SE0201837D0 (sv) * | 2002-06-14 | 2002-06-14 | Astrazeneca Ab | Chemical compounds |
US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
AU2009290474A1 (en) | 2008-09-11 | 2010-03-18 | Pfizer Inc. | Heteroaryls amide derivatives and their use as glucokinase activators |
CA2741783A1 (en) | 2008-10-29 | 2010-05-06 | Taisho Pharmaceutical Co., Ltd. | Compounds having tafia inhibitory activity |
CA2748587A1 (en) | 2009-01-20 | 2010-07-29 | Pfizer Inc. | Substituted pyrazinone amides |
CN102388038B (zh) | 2009-03-11 | 2014-04-23 | 辉瑞大药厂 | 用作葡糖激酶活化剂的苯并呋喃基衍生物 |
AU2010341530B2 (en) | 2009-12-22 | 2016-03-10 | Cephalon, Inc. | Proteasome inhibitors and processes for their preparation, purification and use |
CN102249992A (zh) * | 2011-07-05 | 2011-11-23 | 广东工业大学 | 一种制备2-氨基异烟酸的方法 |
US9919939B2 (en) | 2011-12-06 | 2018-03-20 | Delta Faucet Company | Ozone distribution in a faucet |
WO2014198620A1 (en) | 2013-06-10 | 2014-12-18 | Sanofi | Macrocyclic urea derivatives as inhibitors of tafia, their preparation and their use as pharmaceuticals |
AR099134A1 (es) * | 2014-01-24 | 2016-06-29 | Hoffmann La Roche | Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina |
CN115093008B (zh) | 2015-12-21 | 2024-05-14 | 德尔塔阀门公司 | 包括消毒装置的流体输送系统 |
USD879309S1 (en) | 2018-08-09 | 2020-03-24 | Scott Specialties, Inc. | Maternity support |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3091569A (en) | 1960-08-26 | 1963-05-28 | Mead Johnson & Co | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus |
FR1393338A (fr) | 1964-01-08 | 1965-03-26 | Rech S Pharma Et Scient | Nouveau dérivé de la cystéine et sa préparation |
US3766206A (en) | 1971-11-03 | 1973-10-16 | Pfizer | 18beta-glycyrrheting acid amides useful as antiulcer agents |
FR2266502A1 (en) | 1974-04-08 | 1975-10-31 | Synpharm Sa | N-(2-thenoyl)-cysteine and esters - with mucolytic activity, prepd. from cysteine (esters) and thenoyl chloride |
US4113715A (en) | 1977-01-17 | 1978-09-12 | E. R. Squibb & Sons, Inc. | Amino acid derivatives |
US4177277A (en) | 1977-01-17 | 1979-12-04 | E. R. Squibb & Sons, Inc. | Method for alleviating hypertension |
JPS545949A (en) | 1977-06-16 | 1979-01-17 | Hisamitsu Pharmaceut Co Inc | Novel cyclohexanecarboxylic acid and its derivatives |
FR2430945A2 (fr) | 1978-07-12 | 1980-02-08 | Chauvin Blache Lab | Nouveaux derives de la cysteine, leur procede de fabrication et leur application en therapeutique |
US4537727A (en) | 1982-11-12 | 1985-08-27 | Eli Lilly And Company | Process for recovering 2-acetylthiomethyl-5-aminopentanoic acid |
EP0136883B1 (en) * | 1983-10-03 | 1987-11-25 | E.R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
US4708965A (en) | 1985-09-16 | 1987-11-24 | Morgan Lee R | Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives |
JPS62270555A (ja) * | 1986-05-19 | 1987-11-24 | Dainippon Pharmaceut Co Ltd | スルホン酸誘導体およびその塩 |
EP0318859A3 (en) | 1987-12-03 | 1990-08-16 | Dainippon Pharmaceutical Co., Ltd. | N-substituted mercaptopropanamide derivatives |
JPH01254654A (ja) * | 1988-04-01 | 1989-10-11 | Dainippon Pharmaceut Co Ltd | スルホン酸の誘導体及びその塩 |
EP0361365A1 (en) * | 1988-09-30 | 1990-04-04 | E.R. SQUIBB & SONS, INC. | Aminobenzoic and aminocyclohexane-carboylic acid compounds, compositions, and their method of use |
DE3838467C2 (de) | 1988-11-12 | 1998-12-10 | Agfa Gevaert Ag | Fotografisches Aufzeichnungsmaterial |
ZA911813B (en) | 1990-08-09 | 1991-12-24 | Sankyo Co | (benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma |
IT1249650B (it) | 1991-05-29 | 1995-03-09 | Poli Ind Chimica Spa | N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico |
GB9122016D0 (en) | 1991-10-16 | 1991-11-27 | Glaxo Group Ltd | Chemical compounds |
IT1266571B1 (it) | 1993-07-30 | 1997-01-09 | Zambon Spa | Derivati della beta-mercapto-propanammide utili nel trattamento delle malattie cardiovascolari |
US5470834A (en) * | 1993-10-06 | 1995-11-28 | Florida State University | Sulfoximine and suldodiimine matrix metalloproteinase inhibitors |
DE4441873A1 (de) * | 1994-11-24 | 1996-05-30 | Wella Ag | Mittel zur dauerhaften Haarverformung |
JP3874455B2 (ja) | 1996-06-27 | 2007-01-31 | 新日本製鐵株式会社 | フィブリノーゲン受容体拮抗物質およびそれを有効成分とする医薬製剤 |
-
1999
- 1999-05-03 SE SE9901573A patent/SE9901573D0/xx unknown
-
2000
- 2000-04-28 AR ARP000102083A patent/AR034241A1/es unknown
- 2000-05-02 MY MYPI20001883A patent/MY128014A/en unknown
- 2000-05-03 TR TR2001/03153T patent/TR200103153T2/xx unknown
- 2000-05-03 SK SK1546-2001A patent/SK15462001A3/sk unknown
- 2000-05-03 IL IL14595400A patent/IL145954A0/xx unknown
- 2000-05-03 NZ NZ515062A patent/NZ515062A/en unknown
- 2000-05-03 JP JP2000615388A patent/JP2002543184A/ja active Pending
- 2000-05-03 CN CNB008094829A patent/CN1263739C/zh not_active Expired - Fee Related
- 2000-05-03 CZ CZ20013930A patent/CZ20013930A3/cs unknown
- 2000-05-03 PL PL354360A patent/PL200932B1/pl not_active IP Right Cessation
- 2000-05-03 BR BR0010257-1A patent/BR0010257A/pt active Search and Examination
- 2000-05-03 HU HU0202876A patent/HUP0202876A3/hu unknown
- 2000-05-03 MX MXPA01011055A patent/MXPA01011055A/es active IP Right Grant
- 2000-05-03 EE EEP200100574A patent/EE04490B1/xx not_active IP Right Cessation
- 2000-05-03 RU RU2001128159/04A patent/RU2244708C2/ru not_active IP Right Cessation
- 2000-05-03 CA CA002371213A patent/CA2371213C/en not_active Expired - Fee Related
- 2000-05-03 US US09/600,661 patent/US7071175B1/en not_active Expired - Fee Related
- 2000-05-03 KR KR1020017014011A patent/KR100755152B1/ko not_active IP Right Cessation
- 2000-05-03 EP EP00930001A patent/EP1180098A1/en not_active Withdrawn
- 2000-05-03 AU AU47902/00A patent/AU771760B2/en not_active Ceased
- 2000-05-03 WO PCT/SE2000/000834 patent/WO2000066557A1/en not_active Application Discontinuation
- 2000-05-03 TW TW089108400A patent/TWI232105B/zh not_active IP Right Cessation
-
2001
- 2001-10-30 ZA ZA200108968A patent/ZA200108968B/xx unknown
- 2001-11-01 IS IS6139A patent/IS6139A/is unknown
- 2001-11-02 NO NO20015383A patent/NO321377B1/no not_active IP Right Cessation
-
2002
- 2002-06-06 HK HK02104300.5A patent/HK1042303A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9901573D0 (sv) | New compounds | |
RU95102778A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен | |
GEP20053673B (en) | Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents | |
CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
SE0202462D0 (sv) | Novel use | |
GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
CY1107753T1 (el) | 2,5-δισυποκατεστημενο 3-μερκαπτοπεντανοϊκο οξυ | |
DK0920865T3 (da) | Farmaceutiske sammensætninger indeholdende norastemizol | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
SE0002476D0 (sv) | New compounds | |
SE0102440D0 (sv) | New compound | |
HK1045464A1 (en) | Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease | |
SE9901572D0 (sv) | New compounds | |
DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
UY26459A1 (es) | 3,4-dihidroquinazolinas 5,6-disustituidas | |
DE60233578D1 (de) | Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung | |
SE9900190D0 (sv) | New compounds | |
TW200509915A (en) | Novel oxazoles, their manufacture and use as pharmaceutical agents | |
BRPI0415546A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios | |
ATE301997T1 (de) | Antivirale therapie | |
SE0301904D0 (sv) | Novel imidazopyridine compound II with therapeutic effect | |
GEP20043356B (en) | Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor | |
TW200500330A (en) | Pharmaceutical composition | |
UY27855A1 (es) | Compuestos quimicos |